{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:54Z","timestamp":1787009034654,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Optimal management of Enterococcus faecium bloodstream infection (BSI) is not fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multicentre retrospective observational study of all consecutive adult (\u226518\u2005years old) patients with E. faecium BSI, between January 2016 and December 2023, at two tertiary teaching hospitals in northern Italy. Patients who died within 48\u2005h from BSI onset were excluded. Primary and secondary endpoints were 30\u2005day mortality and persistent E. faecium BSI, respectively. Cox regression and logistic binary analyses were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 391 patients were enrolled: median age was 72 (IQR 61\u201381)\u2005years, 225 were male (57.5%), median Charlson comorbidity index (CCI) was 6 (IQR 4\u20138) and 94 had immunosuppression (24.0%). BSIs were primary, secondary and device-related in 25.1%, 36.2% and 38.7%, respectively. Vancomycin resistance was found in 30.3%. The appropriate empirical therapy rate was given for 29.1%. All-cause 30\u2005day mortality was 34.3% and the rate of persistent BSI was 18.8%. Variables independently associated with 30\u2005day mortality were immunosuppression (HR 1.638, 95% CI 1.022\u20132.625, P\u200a=\u200a0.040), SOFA (HR 1.205, 95% CI 1.144\u20131.268, P\u200a&amp;lt;\u200a0.001), primary BSI (HR 1.839, 95% CI 1.221\u20132.770, P\u200a=\u200a0.004), source control (HR 0.534, 95% CI 0.260\u20130.972, P\u200a=\u200a0.042) and the performance of follow-up blood cultures (HR 0.403, 95% CI 0.280\u20130.972, P\u200a&amp;lt;\u200a0.001). Factors independently associated with persistent E. faecium BSI were: CCI (OR 1.157, 95% CI 1.030\u20131.300, P\u200a=\u200a0.014), source control not performed (OR 3.275, 95% CI 1.113\u20139.635, P\u200a=\u200a0.031) and teicoplanin (OR 2.023, 95% CI 1.018\u20134.018, P\u200a=\u200a0.044).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among modifiable clinical factors in patients with E. faecium BSI, source control and the execution of follow-up blood cultures demonstrated a protective effect on 30\u2005day mortality. Teicoplanin as targeted antibiotic treatment was independently associated with persistent BSI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkaf197","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T07:42:44Z","timestamp":1749282164000},"page":"2247-2256","source":"Crossref","is-referenced-by-count":12,"title":["<i>Enterococcus faecium<\/i>\n                    bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3568-5973","authenticated-orcid":false,"given":"Matteo","family":"Rinaldi","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]},{"name":"Department for Integrated Risk Management, Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-4212","authenticated-orcid":false,"given":"Ilaria","family":"Rancan","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, University of Siena , Siena ,","place":["Italy"]},{"name":"Department of Medical Sciences, Infectious and Tropical Diseases Unit, Siena University Hospital , Siena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Malerba","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-3779","authenticated-orcid":false,"given":"Milo","family":"Gatti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]},{"name":"Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Ancillotti","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, University of Siena , Siena ,","place":["Italy"]},{"name":"Department of Medical Sciences, Infectious and Tropical Diseases Unit, Siena University Hospital , Siena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Tazza","sequence":"additional","affiliation":[{"name":"Department for Integrated Risk Management, Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Campoli","sequence":"additional","affiliation":[{"name":"Department for Integrated Risk Management, Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5661-1324","authenticated-orcid":false,"given":"Cecilia","family":"Bonazzetti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]},{"name":"Department for Integrated Risk Management, Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Profiti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascia","family":"Caroccia","sequence":"additional","affiliation":[{"name":"Department for Integrated Risk Management, Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ambretti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]},{"name":"Department for Integrated Infectious Risk Management, Operative Unit of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Tumbarello","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, University of Siena , Siena ,","place":["Italy"]},{"name":"Department of Medical Sciences, Infectious and Tropical Diseases Unit, Siena University Hospital , Siena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Viale","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]},{"name":"Department for Integrated Risk Management, Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Giannella","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]},{"name":"Department for Integrated Risk Management, Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"2025080100171935200_dkaf197-B1","doi-asserted-by":"publisher","first-page":"e00058-18","DOI":"10.1128\/CMR.00058-18","article-title":"The Enterococcus: a model of adaptability to its environment","volume":"32","author":"Garc\u00eda-Solache","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2025080100171935200_dkaf197-B2","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1128\/AEM.67.4.1628-1635.2001","article-title":"Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates","volume":"67","author":"Eaton","year":"2001","journal-title":"Appl Environ Microbiol"},{"key":"2025080100171935200_dkaf197-B3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5578\/mb.68810","article-title":"[Investigation of antibiotic resistance and virulence factors of Enterococcus faecium and Enterococcus faecalis strains isolated from clinical samples]","volume":"54","author":"G\u00f6k","year":"2020","journal-title":"Mikrobiyol Bul"},{"key":"2025080100171935200_dkaf197-B4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1469-0691.2006.01631.x","article-title":"Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium","volume":"13","author":"Top","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"2025080100171935200_dkaf197-B5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025080100171935200_dkaf197-B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/ice.2015.228","article-title":"VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025080100171935200_dkaf197-B7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jmii.2017.08.025","article-title":"Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia","volume":"51","author":"Ye","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"2025080100171935200_dkaf197-B8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1469-0691.2010.03214.x","article-title":"Management of multidrug-resistant enterococcal infections","volume":"16","author":"Arias","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2025080100171935200_dkaf197-B9","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s10096-024-04917-5","article-title":"Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study","volume":"43","author":"Scharloo","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025080100171935200_dkaf197-B10","doi-asserted-by":"publisher","first-page":"890.e1","DOI":"10.1016\/j.cmi.2016.07.018","article-title":"Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose","volume":"22","author":"Chuang","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2025080100171935200_dkaf197-B11","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10096-022-04481-w","article-title":"Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohort","volume":"41","author":"Rosselli Del Turco","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025080100171935200_dkaf197-B12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jac\/dkf182","article-title":"Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases","volume":"50","author":"Sandoe","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"2025080100171935200_dkaf197-B13","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1155\/2013\/678503","article-title":"Catheter removal versus retention in the management of catheter-associated enterococcal bloodstream infections","volume":"24","author":"Marschall","year":"2013","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2025080100171935200_dkaf197-B14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jgar.2019.10.008","article-title":"Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis","volume":"21","author":"Shi","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"2025080100171935200_dkaf197-B15","doi-asserted-by":"publisher","first-page":"e0005922","DOI":"10.1128\/cmr.00059-22","article-title":"Therapeutics for vancomycin-resistant enterococcal bloodstream infections","volume":"36","author":"Cairns","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"2025080100171935200_dkaf197-B16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"2025080100171935200_dkaf197-B17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2025080100171935200_dkaf197-B18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jclinepi.2003.12.008","article-title":"Time-dependent bias was common in survival analyses published in leading clinical journals","volume":"57","author":"van Walraven","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"2025080100171935200_dkaf197-B19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/1120009X.2018.1516272","article-title":"Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY antimicrobial surveillance program (2010\u20132016): concomitant analysis of oritavancin in vitro activity","volume":"30","author":"Mendes","year":"2018","journal-title":"J Chemother"},{"key":"2025080100171935200_dkaf197-B20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/antibiotics13070601","article-title":"Risk factors for 30-day mortality in nosocomial enterococcal bloodstream infections","volume":"13","author":"Zerbato","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"2025080100171935200_dkaf197-B21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijid.2014.02.012","article-title":"Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study","volume":"26","author":"Billington","year":"2014","journal-title":"Int J Infect Dis"},{"key":"2025080100171935200_dkaf197-B22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jgar.2022.05.003","article-title":"Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study","volume":"29","author":"Bussini","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"2025080100171935200_dkaf197-B23","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/jac\/dkad079","article-title":"Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study","volume":"78","author":"Yamaguchi","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2025080100171935200_dkaf197-B24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ijid.2022.06.029","article-title":"Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: posthoc analysis of a nationwide surveillance","volume":"122","author":"Ha","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2025080100171935200_dkaf197-B25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/microorganisms13010162","article-title":"Usefulness of a TDM-guided approach for optimizing teicoplanin exposure in the treatment of secondary bloodstream infections caused by glycopeptide-susceptible Enterococcus faecium","volume":"13","author":"Gatti","year":"2025","journal-title":"Microorganisms"},{"key":"2025080100171935200_dkaf197-B26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2165\/00003088-200039030-00001","article-title":"Clinical pharmacokinetics of teicoplanin","volume":"39","author":"Wilson","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"2025080100171935200_dkaf197-B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2025080100171935200_dkaf197-B28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2217\/fmb.09.82","article-title":"Transition of Enterococcus faecium from commensal organism to nosocomial pathogen","volume":"4","author":"Willems","year":"2009","journal-title":"Future Microbiol"},{"key":"2025080100171935200_dkaf197-B29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.bmt.1704462","article-title":"Incidence and clinical complications of vancomycin-resistant Enterococcus in pediatric stem cell transplant patients","volume":"33","author":"Tsiatis","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"2025080100171935200_dkaf197-B30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1053\/j.ajkd.2010.12.013","article-title":"Management of Gram-positive coccal bacteremia and hemodialysis","volume":"57","author":"Fitzgibbons","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2025080100171935200_dkaf197-B31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/s12879-021-06328-9","article-title":"Management of enterococcal central line-associated bloodstream infections in patients with cancer","volume":"21","author":"Awadh","year":"2021","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/8\/2247\/63525834\/dkaf197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/8\/2247\/63525834\/dkaf197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T04:17:24Z","timestamp":1754021844000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/8\/2247\/8169093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,6,19]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf197","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,6,19]]}}}